chromium has been researched along with Cancer of Prostate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H; Liu, S; Qie, Y; Shen, C; Wu, Z; Xu, Y; Zhang, C; Zhou, D | 1 |
| Cai, K; Feng, Q; Xu, Y; Zhang, C; Zhang, Z | 1 |
| Antonini, J; Castranova, V; Corum, L; Flynn, DC; Gao, N; Jiang, BH; Leonard, SS; Roberts, JR; Shi, X; Zhang, Z; Zheng, JZ | 1 |
| Jiang, BH; Shi, D | 1 |
| Eberwein, DJ; Ingram, AC; Knick, VC; Murray, DM; Ryan, CH; Stimmel, JB; Thurmond, LM; Witherspoon, SM | 1 |
| JAFFE, HL; RUSCHE, C | 2 |
| GAMBLE, D; GOODWIN, WE; LIBBY, RL; MOORE, V | 1 |
| BULKLEY, GJ; COOPER, JA; O'CONOR, VJ | 1 |
| JAFFE, HL; RUSCHE, CF | 1 |
| Füssel, S; Kiessling, A; Rieber, EP; Rieger, MA; Schmitz, M; Stevanovic, S; Temme, A; Weigle, B | 1 |
| Cole, P; Rodu, B | 1 |
| Franchini, I; Magnani, F; Mutti, A | 1 |
| Andersen, Aa; Gylseth, B; Langård, S | 1 |
| Fournier, GR; Narayan, P; Parivar, F | 1 |
| Adams, J; Hazuka, MB; Ibbott, GS; Kinzie, JJ; Stroud, DN | 1 |
| Peace, DJ; Perambakam, S; Sosman, JA; Xue, BH | 1 |
| Barter, RA; Coogan, TP; Waalkes, MP | 1 |
2 review(s) available for chromium and Cancer of Prostate
| Article | Year |
|---|---|
Epidemiologic studies of chrome and cancer mortality: a series of meta-analyses.
Topics: Central Nervous System Neoplasms; Chromium; Hematologic Neoplasms; Hodgkin Disease; Humans; Kidney Neoplasms; Leukemia; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Stomach Neoplasms | 2005 |
Toxicological principles of metal carcinogenesis with special emphasis on cadmium.
Topics: Animals; Arsenic; Cadmium; Chromium; Confounding Factors, Epidemiologic; DNA; Dose-Response Relationship, Drug; Drug Interactions; Environmental Exposure; Humans; Lung Diseases; Lung Neoplasms; Male; Metals; Mice; Mutagenesis; Neoplasms; Nickel; Occupational Exposure; Prostatic Neoplasms; Rats | 1992 |
1 trial(s) available for chromium and Cancer of Prostate
| Article | Year |
|---|---|
Urethral anastomotic healing after radical retropubic prostatectomy: impact of positive urethral margin.
Topics: Aged; Anastomosis, Surgical; Benzenesulfonates; Catgut; Chromium; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Contraction; Polymers; Postoperative Period; Prostatectomy; Prostatic Neoplasms; Radiography; Reoperation; Sutures; Time Factors; Urethra; Urinary Bladder Diseases; Wound Healing | 1994 |
15 other study(ies) available for chromium and Cancer of Prostate
| Article | Year |
|---|---|
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway.
Topics: Antigens, Neoplasm; Carcinogens, Environmental; Cell Proliferation; Chromium; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction | 2022 |
Chromium(VI) promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
Topics: Carcinogens; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromium; Epithelial-Mesenchymal Transition; Humans; Male; Prospective Studies; Prostatic Neoplasms; Signal Transduction | 2019 |
p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells.
Topics: Antioxidants; Carcinoma; Catalase; Chromium; Electron Spin Resonance Spectroscopy; Endothelial Growth Factors; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mitogen-Activated Protein Kinases; Oxidants; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Antioxidant properties of apple juice and its protection against Cr(VI)-induced cellular injury.
Topics: Antioxidants; Apoptosis; Beverages; Biological Assay; Carcinogens, Environmental; Cell Transformation, Neoplastic; Chemoprevention; Chromium; Comet Assay; DNA Damage; Epithelial Cells; Flow Cytometry; Humans; Lipid Peroxidation; Lung; Male; Malus; NF-kappa B; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured | 2002 |
Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Survival; Chromium; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Female; G2 Phase; Humans; In Vitro Techniques; Lutetium; Male; Mice; Mice, Nude; Mitosis; Paclitaxel; Prostatic Neoplasms; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2003 |
Treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (P32); a preliminary report.
Topics: Chromium; Chromium Compounds; Humans; Male; Phosphates; Prostatic Neoplasms; Radioactivity | 1953 |
Radioactive chromic phosphate in treatment of urological tumors.
Topics: Chromium; Chromium Compounds; Chromium Radioisotopes; Humans; Male; Phosphates; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1955 |
Palliative treatment of prostatic cancer with radioactive colloidal chromic phosphate: three years experience and results.
Topics: Chromium; Chromium Compounds; Humans; Male; Palliative Care; Phosphates; Prostatic Neoplasms | 1955 |
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
Topics: Carcinoma; Chromium; Chromium Compounds; Chromium Radioisotopes; Humans; Male; Phosphates; Prostatic Neoplasms; Yttrium | 1956 |
Treatment of bladder and prostatic cancer by combined interstitial isotope radiation and the cobalt bomb.
Topics: Bombs; Brachytherapy; Chromium; Chromium Radioisotopes; Cobalt; Cobalt Radioisotopes; Humans; Isotopes; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1958 |
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein.
Topics: Aged; Antigens, Neoplasm; CD8-Positive T-Lymphocytes; Chromium; Dendritic Cells; Epitopes, T-Lymphocyte; HLA-A Antigens; HLA-A2 Antigen; Humans; K562 Cells; Male; Membrane Proteins; Middle Aged; Neoplasm Staging; Peptide Fragments; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 2004 |
Mortality experience among chromeplating workers. Initial findings.
Topics: Chromium; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Occupational Diseases; Prostatic Neoplasms; Retrospective Studies | 1983 |
Incidence of cancer among ferrochromium and ferrosilicon workers.
Topics: Aged; Chromium; Chromium Alloys; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Norway; Occupational Diseases; Prostatic Neoplasms; Silicon; Silicon Compounds | 1980 |
Prostatic thermoluminescent dosimeter analysis in a patient treated with 18 MV X rays through a prosthetic hip.
Topics: Chromium; Cobalt; Hip Prosthesis; Humans; Male; Molybdenum; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Thermoluminescent Dosimetry | 1993 |
Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer.
Topics: Aged; Chromium; Cytokines; Enzyme-Linked Immunosorbent Assay; Epitopes; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Interleukin-4; Male; Peptides; Prostate-Specific Antigen; Prostatic Neoplasms; T-Lymphocytes, Cytotoxic; Transfection; Tumor Cells, Cultured | 2002 |